MCL1 and cancer: The balance between MCL-1 and NOXA may determine the susceptibility of cancer cells to drug-induced apoptosis [78], and the degradation of NOXA/MCL-1 complexes has been shown as determining the response of cancer cells to antimitotic treatment [79].